For Residual TNBC Post-Chemo, Capecitabine Should Be Offered

For high-risk patients with triple-negative breast cancer who have residual disease following neoadjuvant therapy, Dr Kathy Miller says we must accept capecitabine as the standard of care. www.medscape.com/index/list_5...

[@alikhalifa1099]

❤❤❤❤thank u for your priceless videoo

[@bennybenny232]

thank you

[@shinl1348]

Hi Dr. Miller, was diagnosed with stage 1B, tumor was 1.2 cm. I had chemo, then surgery and undergoing radiation. They found 1.5mm residual disease that was 5-10% estrogen. Do you think Xeolda would be overtreatement in my case? Oncologist is suggesting it but not sure benefits will outweight side effects. I need to make a decision soon and not sure what to do. Any insight is greatly appreciated. Thank you.

[@shashikantkulkarni5267]

Capacitabine gave adverse effects

[@svetlanapetrovic4758]

What are the negative effects?

[@saradever8912]

All drugs have side effects! Yes, Capecitabine is a hard drug, it’s chemo and it needs to be hard to kill the cancer. It’s saved my life and put me into no detectable cancer in my body! The worst effects are fatigue and hand and foot syndrome. It’s better than dying of stage 4 triple negative breast cancer!